L. Esserman
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 7
- Oncology 13
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- DA Berry (1 shared paper)NM Hylton (1 shared paper)Kelloff Gj (1 shared paper)Amy M. Fulton (1 shared paper)Zoran Antonijevic (1 shared paper)Michael J. Campbell (1 shared paper)Denis Lacombe (1 shared paper)Corina Marx (2 shared papers)
- Journals
- Cancer Research (17 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (3 papers)Clinical Pharmacology & Therapeutics (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesSwedenSwitzerland
In The Last Decade
L. Esserman
38 papers receiving 711 citations
L. Esserman's Hit Papers
Peers
Comparison fields: 5 of 86
- Statistics and Probability 217
- Cancer Research 239
- Oncology 146
- Management Science and Operations Research 53
- Economics and Econometrics 99
Countries citing papers authored by L. Esserman
This map shows the geographic impact of L. Esserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Esserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Esserman more than expected).
Fields of papers citing papers by L. Esserman
This network shows the impact of papers produced by L. Esserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Esserman. The network helps show where L. Esserman may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Esserman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy Hit paper breakdown → | 2009 | 534 |
| 2 | 1995 | 85 | |
| 3 | 2016 | 32 | |
| 4 | Biological therapies for breast carcinoma: concepts for improvement in survival. | 1999 | 16 |
| 5 | 2004 | 10 | |
| 6 | 2009 | 7 | |
| 7 | 2014 | 7 | |
| 8 | 2018 | 6 | |
| 9 | 2018 | 5 | |
| 10 | 2012 | 5 | |
| 11 | 2004 | 5 | |
| 12 | 2013 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 3 | |
| 15 | 2005 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2011 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2009 | 2 |
About L. Esserman
L. Esserman is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 42 papers that have together received 758 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Genomics and Diagnostics (7 papers), Advanced Breast Cancer Therapies (4 papers), MRI in cancer diagnosis (3 papers), BRCA gene mutations in cancer (3 papers), Medical Imaging Techniques and Applications (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Statistics and Probability (217 citations), Cancer Research (239 citations), Oncology (146 citations), Management Science and Operations Research (53 citations) and Economics and Econometrics (99 citations). L. Esserman has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include DA Berry, NM Hylton, Kelloff Gj, Amy M. Fulton, Zoran Antonijevic, Michael J. Campbell, Denis Lacombe, Corina Marx, Ernest C. Borden and Subha Madhavan. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, Clinical Pharmacology & Therapeutics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.